Coverage, Access, and ACIP Recommendations: What Consumers Should Know about Respiratory Vaccines Heading into Fall - CVEEP Skip to main content
Vaccines | Cost and Coverage | COVID-19 | Flu | Infectious Respiratory Diseases | Pertussis (Whooping Cough) | Pneumococcal Disease | RSV

Coverage, Access, and ACIP Recommendations: What Consumers Should Know about Respiratory Vaccines Heading into Fall

Last Updated 10/15/2025

Recent changes to recommendations for respiratory vaccines have left patients and providers with pressing questions about vaccine access and coverage. Following its most recent meeting in September, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended COVID-19 vaccines for those 6 months and older based on “individual decision-making.” This change in recommendation illuminated the need for stakeholders to have clarity on the impact of ACIP recommendations on respiratory vaccine insurance coverage.  

CVEEP hosted a timely discussion on this topic as experts in healthcare coverage, public health, and vaccine policy broke down the relationship between ACIP recommendations and coverage among different types of insurance plans, what to expect at your vaccination appointments this year, and how to advocate for yourself as a patient seeking fall vaccines.

Panelists included: